QuantuMDx Group Limited Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Newcastle upon Tyne, UK
Total Funding:N/A
Industry:Biotech
Founded:2008
Lead Investor(s):N/A

Estimated Revenue & Financials

  • QuantuMDx Group Limited's estimated annual revenue is currently $18.6M per year.
  • QuantuMDx Group Limited's estimated revenue per employee is $155,000

Employee Data

  • QuantuMDx Group Limited has 120 Employees.
  • QuantuMDx Group Limited grew their employee count by 10% last year.
  • QuantuMDx Group Limited currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$46.5M300N/AN/A-N/A
#2
$19.1M123N/AN/A-N/A
#3
$45.7M295N/AN/A-N/A
#4
$10.7M6938%N/A-N/A
#5
$8.1M5244%N/A-N/A
#6
$8.4M5459%N/A-N/A
#7
$50.4M325N/AN/A-N/A
#8
$10.1M6527%N/A-N/A
#9
$29.1M188N/AN/A-N/A
#10
$22.9M148N/AN/A-N/A
Missing a competitor? Contribute!?
Submit

QuantuMDx Group is a multinational life science, tools and diagnostics company with a global vision: to revolutionise molecular diagnostics and help eradicate disease by making accurate diagnostics universally accessible. We have invented the Q-POC, which compresses a molecular diagnostics laboratory into a simple-to-use, portable, affordable device. For just a few pounds per test, it can be used anywhere from basic under-the-tree settings to clinics and hospitals, providing results within 20 minutes. With its high-quality testing for diseases such as TB, HPV and STIs, the battery-operated device aims to bring the power of precision medicine to health professionals globally, enabling patients to be tested, diagnosed and given treatment options in one efficient consultation. Our aim is for geotagged pathogen data from each connected Q-POC to facilitate global disease surveillance and mapping, promoting a joined-up approach to disease control and eradication. Our technologies also have potential utility across many markets including sample preparation, concentration of pathogens from large and complex samples (CAPTURE-XT) and the detection of DNA from humans and pathogens (Q-POC). Headquartered in the UK, QuantuMDx has operations and global partnerships with healthcare providers in the United States, Asia, Europe and Africa keeping it at the forefront of molecular diagnostics.

keywords:N/A

120

Number of Employees

$18.6M

Revenue (est)

1

Current Jobs

10%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

QuantuMDx Group Limited News

09/03/2019 - QuantuMDx Group Ltd has announced plans to expand the potential of its Q-POC™ technology and develop a quality control analytics system for cell and gene therapies (“C>”s), to be evaluated by

Press Release: 17 April 2019. QuantuMDx Group Ltd has announced plans to expand the potential of its Q-POC™ technology and develop a ...

09/08/2019 - Global Dengue Virus Diagnostic Tests Market | Forecast (2019 ...

... Universitas Padjadjaran, QuantuMDx Group Ltd, Sansure Biotech Inc, Quidel Corp, Whidiag SAS, Pictor Ltd, GeneFirst Ltd, Mologic Ltd, ...

09/03/2019 - Global Next Generation Sequencing Market Insights 2019 ...

... Sequencing Market Insights 2019 – SeqLL, LLC, QuantuMDx Group, ... InDecations Exchange Pte Ltd (INEX), Sequenta, Inc., Illumina, Inc., ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
N/A128N/AN/A-N/A
#2
$41.3M128N/AN/A-N/A
#3
$34.6M128N/AN/A-N/A
#4
$18.9M130N/AN/A-N/A
#5
$16.2M13517%N/A-N/A